Risk of cutaneous T-cell lymphoma in atopic dermatitis patients treated with dupilumab and JAK inhibitors: a TriNetX cohort study

Archives of Dermatological Research 2026

View at publisher
Authors: Areeba Ahmed, Dylan Wambold, Joshua G. Burshtein, Brian A. Cahn, Roger Haber
DOI: 10.1007/s00403-025-04501-7
Cited by: 0
References: 5

Fields of Study & Subjects

Dermatology and Skin Diseases Cutaneous lymphoproliferative disorders research Autoimmune Bullous Skin Diseases

Publication details

Journal / source
Archives of Dermatological Research
Volume
318
Issue
1
Publication date
3 January 2026
Language
EN